Andre Ricardo Araujo da Silva
Overview
Explore the profile of Andre Ricardo Araujo da Silva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
730
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campos L, Fonseca A, Oliveira T, Lino K, Paes Leme F, Torbey A, et al.
Pediatr Infect Dis J
. 2024 Dec;
44(1):e31-e32.
PMID: 39705407
No abstract available.
2.
Pereira G, Araujo da Silva A, Pitanga C, Lugon J
J Vasc Bras
. 2024 Sep;
23:e20230175.
PMID: 39286302
The first case of COVID-19 was detected in Dec 2019, in China. The disease shortly evolved into a pandemic and imposed an unparalleled health and social burden on mankind. Severe...
3.
Araujo da Silva A, Quijada R
Children (Basel)
. 2024 Jun;
11(6).
PMID: 38929243
Background: Ceftazidime-Avibactam (CAZ-AVI) is one of the new antibiotics available to treat infections due to carbapenem-resistant gram-negative bacteria (CRB). Our aim was to describe the use of CAZ-AVI in children...
4.
Araujo da Silva A, de Carvalho B, Esteves M, Teixeira C, Souza C
Vaccines (Basel)
. 2022 Apr;
10(4).
PMID: 35455368
Objective: To evaluate COVID-19 vaccination status in admitted children in 2020−2021 and during the OMICRON variant circulation (2022), a period when children older than 12 years of age had received...
5.
Dramowski A, Bekker A, Anugulruengkitt S, Bayani O, Goncalves F, Naizgi M, et al.
Pediatr Infect Dis J
. 2022 Feb;
41(3S):S36-S39.
PMID: 35134038
Infection prevention challenges are ubiquitous in healthcare, but some are unique to or more prevalent in low-and middle-income country settings. Despite limited resources, innovative and committed paediatric healthcare providers and...
6.
Fitzgerald F, Zingg W, Chimhini G, Chimhuya S, Wittmann S, Brotherton H, et al.
Pediatr Infect Dis J
. 2022 Feb;
41(3S):S26-S35.
PMID: 35134037
Background: Clinically suspected and laboratory-confirmed bloodstream infections are frequent causes of morbidity and mortality during neonatal care. The most effective infection prevention and control interventions for neonates in low- and...
7.
Lamontagne F, Stegemann M, Agarwal A, Agoritsas T, Siemieniuk R, Rochwerg B, et al.
BMJ
. 2021 Mar;
372:n526.
PMID: 33649077
Clinical Question: What is the role of drugs in preventing covid-19? WHY DOES THIS MATTER?: There is widespread interest in whether drug interventions can be used for the prevention of...
8.
Agarwal A, Hunt B, Stegemann M, Rochwerg B, Lamontagne F, Ac Siemieniuk R, et al.
BMJ
. 2020 Sep;
370:m3379.
PMID: 32887691
Updates: This is the fourteenth version (thirteenth update) of the living guideline, replacing earlier versions (available as data supplements). New recommendations will be published as updates to this guideline. Clinical...
9.
Janssens K, Sobrinho Valete C, Araujo da Silva A, Ferman S
J Pediatr (Rio J)
. 2020 Jun;
97(3):302-308.
PMID: 32505617
Objective: To evaluate the performance of risk stratification protocols for febrile neutropenia specific to the pediatric population. Methods: Retrospective study of a cohort of pediatric patients undergoing cancer treatment with...
10.
Araujo da Silva A, Jaszkowski E, Schober T, von Both U, Meyer-Buehn M, Hubner A, et al.
Infection
. 2020 May;
48(4):569-575.
PMID: 32430646
Purpose: Recommendations regarding the optimal number of blood cultures in children are not available. The aim of this article is to describe the correlation between blood culture (BC) rates and...